Advanced Enzyme Q4 PAT Surges 69% YoY to ₹453M

Advanced Enzyme Technologies reported Q4 FY26 consolidated revenue of ₹2,034 million, up 22% YoY, with PAT surging 69% to ₹453 million.
Human Nutrition segment led growth with 24% YoY increase to ₹1,281 million, while domestic sales grew 51% to ₹1,061 million.
The company announced expansion of its B2C nutraceutical brand Wellfa in India and plans to explore strategic acquisitions using internal accruals.
FY26 annual performance showed revenue of ₹7,458 million (+17% YoY) and PAT of ₹1,736 million (+30% YoY), with EBITDA margin stable at 31%.